![Lars Nieba](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Nieba
Vorstandsvorsitzender bei
Engimmune Therapeutics AG
Profil
Lars Nieba currently works at Engimmune Therapeutics AG, as Chief Executive Officer & Director from 2023.
Dr. Nieba also formerly worked at Bayer AG, as Vice President from 2016 to 2019, Nordic Nanovector ASA, as Chief Executive & Technology Officer from 2020 to 2021, and Pureos Partners AG, as Venture Partner from 2021 to 2023.
Dr. Nieba received his graduate degree in 1993 from the University of Freiburg, Masters Business Admin degree in 2003 from the University of St. Gallen, and doctorate degree in 1997 from the University of Zurich.
Aktive Positionen von Lars Nieba
| Unternehmen | Position | Beginn |
|---|---|---|
Engimmune Therapeutics AG
 Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Vorstandsvorsitzender | 19.04.2023 |
Ehemalige bekannte Positionen von Lars Nieba
| Unternehmen | Position | Ende |
|---|---|---|
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions. | Private Equity Investor | 30.04.2023 |
| BAYER AG | Corporate Officer/Principal | 01.11.2019 |
| THOR MEDICAL | Vorstandsvorsitzender | 06.04.2021 |
Ausbildung von Lars Nieba
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions. | Finance |
Engimmune Therapeutics AG
Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Health Technology |
